• 8:30 - 18:00 M-T / 8.30 - 15.00 F

Reoxcare was very well received at the SGH Congress

Print

The 13th and 14th of September was held in Vigo (Galicia, Spain) the IV Congreso SGH (Galician Wound Society), and Histocell took part in this event, participating as an exhibitor, and holding a symposium within the scientific program.

The SGH Congress is held bianually and aims to bring together all the health professionals united by their interest in applying excellent care to patients suffering from deterioration of skin and/or tissue integrity.

Many people visited our Reoxcare stand, among the 500 participants who attended this event, and who had the opportunity to get first-hand knowledge of the benefits of using the dressing, marketed in Spain in 2018.

SGH

Reoxcare is available internationally in Colombia, Chile, Peru and Mexico in America, as well as The Netherlands, Serbia and Italy in Europe, with a short-term expansion plan for Jordan, Saudi Arabia, Ecuador, Panama, Germany, Greece and Cyprus.

Once more, Histocell sponsored one of the symposiums that took place within the scientific program, which gathered more than 100 people, entitled "Overcoming the stress of the complex wound: natural antioxidant technology." The symposium informed, thanks to Teresa Segovia, nurse expert in wounds and member of the Steering Committee of the GNEAUPP and Begoña Castro, Scientific Director of Histocell, about the key element of the success of the Reoxcare dressing: its antioxidant components, which allow fighting against reactive oxygen species that cause wound stagnation.

Our scientific and commercial team is at your disposal to clarify any doubt about the product or its use, so do not hesitate to contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..

About Reoxcare

Reoxcare® is a dressing of natural origin, unique within the range of products so far used for the treatment of chronic wounds. With more than 30 preclinical and clinical studies carried out, Reoxcare® has demonstrated unique antioxidant properties and the ability to induce a natural healing in highly inflammatory environments, the main cause of the chronification of wounds such as ulcers of vascular origin, Diabetic foot ulcers or pressure ulcers.

Chronic wounds are a serious health and economic problem worldwide. It is estimated that there are about 175 million new cases every year, including pressure ulcers, vascular or diabetic. 28 million people suffer from chronic wounds annually and the estimated market this year for the treatment of these injuries is more than 5,000 million euros.

Histocell

Histocell, S.L.
Parque Tecnológico 801A, 2º
48160 Derio
Bizkaia - Spain

+34 94 656 7900
info@histocell.com
www.histocell.com

Our values

We develop new healthcare products and cell therapy drugs to improve people's quality of life.

Copyright © Histocell